Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eduardo J Duque

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Current Opinion in Nephrology and Hypertension|April 1, 2025
The role of osteopontin in chronic kidney disease-mineral bone disorderEduardo J Duque, Cecilia Giachelli, Rosa M A Moysés
Current Opinion in Nephrology and Hypertension|June 15, 2022
Phosphate balance during dialysis and after kidney transplantation in patients with chronic kidney diseaseEduardo J Duque, Rosilene M Elias, Rosa M A Moysés
Toxins|March 21, 2020
Parathyroid Hormone: A Uremic ToxinEduardo J Duque, Rosilene M Elias, Rosa M A Moysés
Journal of Nephrology|November 2, 2022
Nephrology picture: bone loss due to absence of adequate therapy for severe secondary hyperparathyroidismEduardo J Duque, Rosilene M Elias, Vanda Jorgetti, et al.
Kidney360|June 2, 2026
High Prevalence of Secondary Hyperparathyroidism Prior to Kidney Transplantation in Brazil: A Perfect Storm for Adverse Graft OutcomesLorena C Mainardes, Eduardo J Duque, Elias David-Neto, et al.
Jornal Brasileiro De Nefrologia|June 17, 2025
Serum parathyroid hormone trajectory during the first year of hemodialysis: a roadmap to severe hyperparathyroidismEduardo J Duque, Maria Eugenia F Canziani, Ana Beatriz L Barra, et al.
Kidney International|April 29, 2026
Estrogen protects female mice with chronic kidney disease from fibroblast growth factor 23-induced left ventricular hypertrophyDominik Kentrup, Jane Joy Thomas, Guillaume Courbon, et al.
JBMR Plus|December 22, 2023
Corneal and Coronary Calcification in Maintenance Hemodialysis: The Face Is No Index to the HeartMaria Beatriz C N Pessoa, Ruth Miyuki Santo, Aline A de Deus, et al.
Blood|April 21, 2026
Erythroid-produced intact FGF23 is a paracrine inhibitor of erythropoiesisGuillaume Courbon, Jane J Thomas, Eduardo J Duque, et al.
JBMR Plus|July 29, 2024
The role of osteopontin and osteocyte-derived factors in secondary hyperparathyroidism-induced myopathyEduardo J Duque, Shirley F Crispilho, Ivone B Oliveira, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Opinion in Nephrology and Hypertension|April 1, 2025
The role of osteopontin in chronic kidney disease-mineral bone disorderEduardo J Duque, Cecilia Giachelli, Rosa M A Moysés
Current Opinion in Nephrology and Hypertension|June 15, 2022
Phosphate balance during dialysis and after kidney transplantation in patients with chronic kidney diseaseEduardo J Duque, Rosilene M Elias, Rosa M A Moysés
Toxins|March 21, 2020
Parathyroid Hormone: A Uremic ToxinEduardo J Duque, Rosilene M Elias, Rosa M A Moysés
Journal of Nephrology|November 2, 2022
Nephrology picture: bone loss due to absence of adequate therapy for severe secondary hyperparathyroidismEduardo J Duque, Rosilene M Elias, Vanda Jorgetti, et al.
Kidney360|June 2, 2026
High Prevalence of Secondary Hyperparathyroidism Prior to Kidney Transplantation in Brazil: A Perfect Storm for Adverse Graft OutcomesLorena C Mainardes, Eduardo J Duque, Elias David-Neto, et al.
Jornal Brasileiro De Nefrologia|June 17, 2025
Serum parathyroid hormone trajectory during the first year of hemodialysis: a roadmap to severe hyperparathyroidismEduardo J Duque, Maria Eugenia F Canziani, Ana Beatriz L Barra, et al.
Kidney International|April 29, 2026
Estrogen protects female mice with chronic kidney disease from fibroblast growth factor 23-induced left ventricular hypertrophyDominik Kentrup, Jane Joy Thomas, Guillaume Courbon, et al.
JBMR Plus|December 22, 2023
Corneal and Coronary Calcification in Maintenance Hemodialysis: The Face Is No Index to the HeartMaria Beatriz C N Pessoa, Ruth Miyuki Santo, Aline A de Deus, et al.
Blood|April 21, 2026
Erythroid-produced intact FGF23 is a paracrine inhibitor of erythropoiesisGuillaume Courbon, Jane J Thomas, Eduardo J Duque, et al.
JBMR Plus|July 29, 2024
The role of osteopontin and osteocyte-derived factors in secondary hyperparathyroidism-induced myopathyEduardo J Duque, Shirley F Crispilho, Ivone B Oliveira, et al.
Pageof 1